Clinical Trial Update: A Study of RO6870810/TEN-010 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndrome [Phase 1]

View source ↗

Summary

Phase 1 study of RO6870810/TEN-010 in patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• RO6870810/TEN-010

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1 | Status: COMPLETED